Obama Falsely Claims Embryonic Stem Cell Research Will Cure Alzheimer’s
by Steven Ertelt
March 25, 2009
Washington, DC (LifeNews.com) — During his press conference last night, President Barack Obama repeated the false claim that embryonic stem cell research will cure Alzheimer’s. That’s despite numerous top level scientists saying the disease is one of the ones that is virtually unlikely to be affected by embryonic stem cell research.
Obama was asked about the ethics of his decision to overturn the Bush executive order protecting taxpayers from funding research involving the destruction of human life.
"I think that the guidelines that we provided meet that ethical test," he said.
"What we have said is that for embryos that are typically about to be discarded, for us to be able to use those in order to find cures for Parkinson’s or for Alzheimer’s, or for, you know, all sorts of other debilitating diseases, juvenile diabetes, that — that it is the right thing to do," he claimed.
But Wesley J. Smith, a bioethics expert, points out that Obama is misleading the country with his comments.
"Alzheimer’s is not the kind of a disease likely to be cured by embryonic stem cell infusions because it is caused by plaques that attack the whole brain," he explains.
Leading scientists agree and say that embryonic stem cell research will likely never yield a cure for Alzheimer’s.
"Alzheimer’s is a more global disease, with an effect on numerous kinds of cells," Steve Stice, a stem cell researcher at the University of Georgia, told the Atlanta Journal-Constitution newspaper previously. "That makes it much more difficult for a cell therapy to be effective."
Other researchers agree that potential cures, if they come about, won’t happen soon.
"I think the chance of doing repairs to Alzheimer’s brains by putting in stem cells is small," stem cell researcher Michael Shelanski, of Columbia University Medical Center in New York, told the Washington Post in June 2004. "I personally think we’re going to get other therapies for Alzheimer’s a lot sooner."
In a patient afflicted with Alzheimer’s, clumps of protein called amyloid build up within the brain and begin attacking various types of cells and the connections between cells.
Knowing that, Huntington Potter, a brain researcher at the University of South Florida in Tampa, says, "The complex architecture of the brain, the fact that it’s a diffuse disease with neuronal loss in numerous places and with synaptic loss, all this is a problem."
Marilyn Albert, Johns Hopkins University researcher who chairs the Medical and Scientific Advisory Council of the Alzheimer’s Association, says there are more promising efforts to treat the disease than waiting on the decades it could take to see results from embryonic stem cells.
"I just think everybody feels there are higher priorities for seeking effective treatments for Alzheimer’s disease and for identifying preventive strategies," she previously told the Associated Press.
Marcelle Morrison-Bogorad, associate director of the National Institute on Aging’s neuroscience and neuropsychology of aging program, concurs.
"There’s an awful lot going on right now that perhaps holds a little bit more immediate promise for trying to slow the disease, or even cut off its development," Morrison-Bogorad explained.
Even Ron Reagan, son of former President Ronald Reagan, admitted in an interview on MSNBC’s "Hardball" in July 2004 that embryonic stem cell research is unlikely to provide cures for the debilitating disease.
"Alzheimer’s is a disease, ironically, that probably won’t be amenable to treatment through stem cell therapies," Reagan admitted.
If any stem cell therapy will work, it appears the use of adult stem cells, which Bush supported and funded, may be the leading kind.
In March 2008, scientists at the Cryo-Cell International found that targeted immune suppression using stem cells derived from human umbilical cord blood may reduce the progression of Alzheimer’s disease.
For the study, researchers had administered a series of low-dose infusions of umbilical cord blood cells into mice with abnormalities mimicking Alzheimer’s disease.
According to the organizations announcement, researchers found that the two main markers of Alzheimer’s progression in the brain were reduced as a result of the infusions myloid-beta proteins by 62 percent and cerebral amyloid angiopathy by 86 percent.
This is the second time since his election that Obama made false promises about embryonic stem cell research and Alzheimer’s.
In January, in comments to CNN, he said that "on embryonic stem cell research … there is a moral and ethical mechanism to ensure that people with Parkinson’s disease and Alzheimer’s can actually find potentially some hope out there."
Sign Up for Free Pro-Life News From LifeNews.com
Daily Pro-Life News Report Twice-Weekly Pro-Life
News Report Receive a free daily email report from LifeNews.com with the latest pro-life news stories on abortion, euthanasia and stem cell research. Sign up here. Receive a free twice-weekly email report with the latest pro-life news headlines on abortion, euthanasia and stem cell research. Sign up here.